Foot drop during adalimumab therapy for Crohn disease

Gastroenterol Hepatol. 2016 Dec;39(10):724-725. doi: 10.1016/j.gastrohep.2016.04.003. Epub 2016 May 13.

[Article in English, Spanish]

Authors

Mónica Collazo Diéguez¹, Víctor González Carrera²

Affiliations

¹ Servicio de Medicina Física y Rehabilitación, Complexo Hospitalario Universitario de Ourense, Ourense, España. Electronic address: monicacodi@hotmail.com.
² Servicio de Aparato Digestivo, Complexo Hospitalario Universitario de Ourense, Ourense, España.

PMID: 27184553
DOI: 10.1016/j.gastrohep.2016.04.003

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adalimumab / adverse effects*
Adalimumab / therapeutic use
Adult
Crohn Disease / complications
Crohn Disease / drug therapy*
Electromyography
Foot / innervation
Humans
Male
Peripheral Nervous System Diseases / chemically induced*
Peripheral Nervous System Diseases / rehabilitation
Peripheral Nervous System Diseases / therapy
Physical Therapy Modalities
Sciatic Nerve / drug effects
Sciatic Nerve / physiopathology
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Tumor Necrosis Factor-alpha
Adalimumab